Paxalisib in DPG - I did not clarify in that post from 20 minutes ago.
-------------------------------------
Also worth putting this up below, also - it certainly is current information.
Its shows the scale of success or otherwise - of cancer drug development.
Needless to say, for any new readers here - Kazia has clinical trials underway for lung cancers that have moved to the brain. Lung cancer in the brain - extremely likely for paxalisib to work outside of the CNS also. But anyway - I am just presenting here more of the same stuff........................
There are 100 research papers on google which explains that many cancers escape through these errant PI3K pathways. Paxalisib is a drug that repairs these damaged pathway, so as to work in combination with "household" name type cancer drug.
But no 14 billion here, that is for sure - maybe the odd 1 or 2 cent pip increase in SP, can appeal to investors, becoming a little desensitized to disappointment here.
---------------------
July 2023
AstraZeneca stock value falls by nearly £14bn after cancer drug trial results
Shares close down 8% on concerns that new lung cancer drug may not be as successful as hoped
Nearly £14bn has been wiped off the stock market value of AstraZeneca over concerns that a new lung cancer drug may not be as successful as had been hoped.
- Forums
- ASX - By Stock
- KZA
- Comparisions other Drug Companies
Comparisions other Drug Companies, page-2
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online